A recent narrative review looks at the most effective and emerging options for diagnosing and treating basal cell carcinoma.

Medicus Pharma CEO Dr Raza Bokhari joined Steve Darling from Proactive to announce that the company has submitted an Orphan ...

Basal cell carcinoma has low immunogenicity. Tumor cells express Foxc1 protein (red), which suppresses HLA class I (green) in the tumor cells. Compromised antigen presentation ranks among the top ...

Basal cell carcinoma (BCC) represents the most prevalent form of skin cancer, with research efforts increasingly focused on elucidating its molecular underpinnings and improving therapeutic strategies ...

Repeated periocular and facial irradiation contributes to lasting cosmetic and functional changes that can intensify distress ...

July 21, 2012 (Miami Beach, Florida) — Basal cell carcinoma, the most common type of skin cancer, can be effectively treated with a radioactive skin patch containing phosphorus 32, researchers said ...

Detailed price information for Verrica Pharmaceuticals Inc (VRCA-Q) from The Globe and Mail including charting and trades.